Related Experiment Video

Updated: Jul 14, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiency

Kristin Strumane1, Ji-Ying Song, Inge Baas

  • 1Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Leukemia Research
|May 25, 2007
PubMed

Insights

Loss of PTEN function in T-cells promotes lymphoma. While Tiam1 deficiency increased lymphoma invasion, it paradoxically enhanced Rac activity, suggesting alternative pathways drive tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • PTEN (phosphatase and tensin homolog) normally suppresses the PI3K/Akt pathway, inhibiting cell proliferation and promoting apoptosis.
  • PI3K activation is implicated in tumor formation, potentially via PKB/Akt signaling and Rho-GTPase activation, promoting invasion.
  • Tiam1 is a known activator of Rac, a Rho-GTPase involved in cell motility and invasion.

Purpose of the Study:

  • To investigate the role of Tiam1 in PI3K-induced T-lymphomagenesis.
  • To understand the interplay between PTEN loss, PI3K signaling, and Rac activation in T-cell lymphoma development and invasion.

Main Methods:

  • Utilized a mouse model with T cell-specific Pten deletion to induce T-lymphomas.
  • Compared tumor invasion and Rac activity in Tiam1-deficient and wild-type mice.
  • Analyzed PKB/Akt phosphorylation as a marker of PI3K pathway activation.

Main Results:

  • T cell-specific Pten deletion led to T-lymphomas with increased PKB/Akt phosphorylation.
  • Tiam1-deficient lymphomas exhibited more frequent infiltration into various organs compared to wild-type.
  • Surprisingly, Tiam1-deficient lymphomas displayed elevated Rac activity, indicating compensatory mechanisms.

Conclusions:

  • Tiam1 is not essential for PI3K-induced T-lymphomagenesis, despite its role in Rac activation.
  • Alternative Rac-activating pathways can compensate for Tiam1 loss, leading to enhanced lymphoma invasion.
  • These findings suggest complex regulatory networks governing tumor progression in the context of PTEN loss.

More Related Videos

Isolation and Characterization of Neutrophils with Anti-Tumor Properties10:15

Isolation and Characterization of Neutrophils with Anti-Tumor Properties

Published on: June 19, 2015

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: